Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 14,435 |
|
|||||
| News | - | ||||||
| Day High | 0.74 | Low High |
|||||
| Day Low | 0.70 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Alzamend Neuro Inc | ALZN | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.047 | 6.71% | 0.747 | 09:53:24 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.74 | 0.70 | 0.74 | 0.719501 | 0.70 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 115 | 14,435 | US$ 0.7293921 | US$ 10,529 | - | 0.6516 - 11.91 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 08:29:57 | 1 | US$ 0.75 | USD |
Alzamend Neuro Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 5.13M | 7.12M | - | 0 | -14.88M | -2.09 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Alzamend Neuro News
| Date | Time | Source | News Article |
|---|---|---|---|
| 08/3/2024 | 08:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 03/2/2024 | 08:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 06/1/2024 | 08:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 16/12/2023 | 08:30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 12/12/2023 | 00:00 | Business Wire | Alzamend Neuro Receives FDA “Study May Proceed” Notification.. |
| 21/11/2023 | 00:00 | Business Wire | Alzamend Neuro Receives FDA “Study May Proceed” Notification.. |
| 17/11/2023 | 08:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 17/11/2023 | 00:00 | Business Wire | Alzamend Neuro Regains Compliance with Nasdaq’s Minimum Bid.. |
| 14/11/2023 | 00:00 | Business Wire | Alzamend Neuro Submits IND Application for a Phase IIA.. |
| 31/10/2023 | 07:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 30/10/2023 | 23:00 | Business Wire | Alzamend Neuro Announces Reverse Stock Split |
| 23/10/2023 | 23:00 | Business Wire | Alzamend Neuro Submits IND Application for a Phase IIA.. |
Historical ALZN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.714 | 0.74 | 0.6516 | 0.694911 | 28,177 | 0.033 | 4.62% |
| 1 Month | 0.99 | 0.99 | 0.6516 | 0.8149635 | 47,249 | -0.243 | -24.55% |
| 3 Months | 0.8815 | 1.29 | 0.6516 | 0.9977988 | 57,944 | -0.1345 | -15.26% |
| 6 Months | 2.931 | 3.00 | 0.6516 | 1.30 | 114,107 | -2.18 | -74.51% |
| 1 Year | 8.25 | 11.91 | 0.6516 | 4.19 | 149,432 | -7.50 | -90.95% |
| 3 Years | 435.00 | 503.25 | 0.6516 | 41.99 | 1,221,391 | -434.25 | -99.83% |
| 5 Years | 435.00 | 503.25 | 0.6516 | 41.99 | 1,221,391 | -434.25 | -99.83% |
